桑黄酮G通过调控PI3K/AKT/mTOR通路抑制胃癌细胞的生长、迁移和侵袭

doi:10.12122/j.issn.1673-4254.2024.08.06

南方医科大学学报 ›› 2024, Vol. 44 ›› Issue (8): 1476-1484.doi: 10.12122/j.issn.1673-4254.2024.08.06

• • 上一篇

桑黄酮G通过调控PI3K/AKT/mTOR通路抑制胃癌细胞的生长、迁移和侵袭

耿志军¹^,⁴(), 杨晶晶², 牛民主³, 刘馨悦⁴, 施金冉⁴, 刘亦珂⁴, 姚新宇⁴, 张雨路⁴, 张小凤¹^,⁴, 胡建国⁴^,⁵()

^1.蚌埠医科大学第一附属医院，中心实验室，安徽蚌埠 233004
^2.蚌埠医科大学第一附属医院，胃肠外科，安徽蚌埠 233004
^5.蚌埠医科大学第一附属医院，检验科，安徽蚌埠 233004
^3.蚌埠医科大学检验医学院免疫学教研室，安徽蚌埠 233000
^4.炎症相关性疾病基础与转化研究安徽省重点实验室，安徽蚌埠 233004

收稿日期:2024-04-12 出版日期:2024-08-20 发布日期:2024-09-06
通讯作者: 胡建国 E-mail:gengzhijun1213@bbmc.edu.cn;jghu9200@bbmc.edu.cn
作者简介:耿志军，研究实习员，E-mail: gengzhijun1213@bbmc.edu.cn
基金资助:
安徽省高校协同创新项目(GXXT-2020-020);安徽省高等学校自然科研究项目(KJ2020A0563);安徽省卫生健康科研项目(AHWJ2022b088)

Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway

Zhijun GENG¹^,⁴(), Jingjing YANG², Minzhu NIU³, Xinyue LIU⁴, Jinran SHI⁴, Yike LIU⁴, Xinyu YAO⁴, Yulu ZHANG⁴, Xiaofeng ZHANG¹^,⁴, Jianguo HU⁴^,⁵()

^1.Central Laboratory,
^2.Department of Gastrointestinal Surgery,
^5.Clinical Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu 233003, China
^3.Department of Immunology, School of Laboratory Medicine, Bengbu Medical University, Bengbu 233000, China
^4.Anhui Provincial Key Laboratory of Basic and Translational Research of Inflammation-related Diseases, Bengbu 233003, China

Received:2024-04-12 Online:2024-08-20 Published:2024-09-06
Contact: Jianguo HU E-mail:gengzhijun1213@bbmc.edu.cn;jghu9200@bbmc.edu.cn

摘要/Abstract

摘要：

目的探讨桑黄酮G（KG）对胃癌细胞的增殖、凋亡、迁移和侵袭的作用和分子机制。方法通过CCK-8实验、细胞克隆形成实验、裸鼠背部成瘤和Ki-67免疫组织化学染色评估不同浓度KG对胃癌细胞增殖与生长的影响；应用Annexin V-FITC/PI细胞凋亡检测试剂盒、Western blotting分析凋亡相关蛋白表达和Tunel染色评估KG对胃癌细胞凋亡的影响；使用Transwell迁移和侵袭实验与Western blotting分析基质金属蛋白酶表达检测KG对胃癌细胞迁移和侵袭的作用；利用免疫印迹技术和rescue实验验证PI3K/AKT/mTOR通路在KG调控胃癌细胞的增殖、迁移和侵袭的作用。结果 KG以浓度依赖性抑制胃癌细胞的增殖和减少细胞形成克隆数（P<0.05）；KG上调凋亡细胞比例，促进cleaved caspase-3、Bcl2-Bax表达并下调Bcl2水平（P<0.05）；KG干扰胃癌细胞的迁移和侵袭，并且抑制基质金属蛋白酶2（MMP2）和基质金属蛋白酶9（MMP9）的表达（P<0.05）。机制验证显示，KG抑制PI3K/AKT/mTOR通路的激活，且PI3K/AKT/mTOR通路的激活剂IGF-1逆转了KG对胃癌细胞增殖、迁移和侵袭的影响（P<0.05）。结论 KG至少部分是通过抑制PI3K/AKT/mTOR通路的激活影响胃癌细胞的增殖、凋亡、迁移和侵袭。

关键词: 胃癌, 桑黄酮G, 恶性行为, PI3K/AKT/mTOR通路

Abstract:

Objective To investigate the effects of kuwanon G (KG) on proliferation, apoptosis, migration and invasion of gastric cancer cells and the molecular mechanisms. Methods The effects of KG on proliferation and growth of gastric cancer cells were assessed with CCK-8 assay and cell clone formation assay, by observing tumor formation on the back of nude mice and using immunohistochemical analysis of Ki-67. The effect of KG on cell apoptosis was analyzed using Annexin V-FITC/PI apoptosis detection kit, Western blotting and TUNEL staining. The effects of KG on cell migration and invasion were detected using Transwell migration and invasion assay and Western blotting for matrix metalloproteinase (MMP). The role of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway in KG-mediated regulation of gastric cancer cell proliferation, migration, and invasion was verified by Western blotting and rescue assay. Results KG significantly inhibited proliferation and reduced clone formation ability of gastric cancer cells in a concentration-dependent manner (P<0.05). KG treatment also increased apoptosis, enhanced the expressions of cleaved caspase-3 and Bax, down-regulated Bcl-2, lowered migration and invasion capacities and inhibited the expression of MMP2 and MMP9 in gastric cancer cells (P<0.05). Mechanistic validation showed that KG inhibited the activation of the PI3K/AKT/mTOR pathway, and IGF-1, an activator of the PI3K/AKT/mTOR pathway, reversed the effects of KG on proliferation, migration and invasion of gastric cancer cells (P<0.05). Conclusion KG inhibits proliferation, migration and invasion and promotes apoptosis of gastric cancer cells at least in part by inhibiting the activation of the PI3K/AKT/mTOR pathway.

Key words: gastric cancer, kuwanon G, malignant behaviors, PI3K/AKT/mTOR pathway

耿志军, 杨晶晶, 牛民主, 刘馨悦, 施金冉, 刘亦珂, 姚新宇, 张雨路, 张小凤, 胡建国. 桑黄酮G通过调控PI3K/AKT/mTOR通路抑制胃癌细胞的生长、迁移和侵袭[J]. 南方医科大学学报, 2024, 44(8): 1476-1484.

Zhijun GENG, Jingjing YANG, Minzhu NIU, Xinyue LIU, Jinran SHI, Yike LIU, Xinyu YAO, Yulu ZHANG, Xiaofeng ZHANG, Jianguo HU. Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway[J]. Journal of Southern Medical University, 2024, 44(8): 1476-1484.

图/表 6

图1 KG对胃癌细胞增殖的影响

Fig.1 Effect of KG on proliferation of gastric cancer cells. A, D, E, H: CCK-8 assay for assessing proliferative activity of gastric cancer cells. B, C, F, G: Number of gastric cancer cell clones in colony formation assay. *P<0.05 vs Control, 0 μmol/L.

图3 KG对胃癌细胞迁移和侵袭的影响

Fig.3 KG inhibits migration and invasion of gastric cancer cells. A-D: Transwell migration and invasion assay for analyzing cell migration and invasion. E, F: Western blotting and quantification of MMP2 and MMP9 expressions. *P<0.05 vs Control (0 μmol/L).

图4 KG抑制胃癌细胞增殖、迁移和侵袭与PI3K/AKT/mTOR通路的相关

Fig.4 KG-induced inhibition of gastric cancer cell proliferation, migration and invasion is correlated with activation of the PI3K/AKT/mTOR pathway. A, B: Western blotting and quantification of p-PI3K, PI3K, p-AKT, AKT, p-mTOR and mTOR expressions. C: CCK-8 assay for assessing cell proliferative activity. D, E: Western blotting and quantification of MMP2 and MMP9 expressions. *P<0.05 vs Control, #P<0.05 vs KG.

图5 裸鼠体内验证KG对移植瘤生长的影响

Fig.5 Effect of KG on subcutaneous xenograft growth in nude mice. A, C: Volume and size of the xenografts in different groups. B: Immunohistochemistry for and quantitative analysis of Ki-67 expression in the xenografts. *P<0.05 vs Con.

图6 在体研究KG对胃癌细胞凋亡和侵袭的影响

Fig.6 Effect of KG on apoptosis and invasion of gastric cancer cells in nude mice. A, B: TUNEL staining of the xenografts. C, D: Western blotting and quantification of cleaved-caspase 3, Bax and Bcl2 expressions. E, F: Western blotting and quantification of MMP2 and MMP9 expressions. *P<0.05 vs Control.

图7 在体研究KG对PI3K/AKT/mTOR通路的影响

Fig.7 Effect of KG on the PI3K/AKT/mTOR pathway the xenografts in nude mice. A, B: Western blotting and quantification of p-PI3K, PI3K, p-AKT, AKT, p-mTOR and mTOR expressions. *P<0.05 vs Con.

参考文献 32

1	Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-48.
2	Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives[J]. J Hematol Oncol, 2023, 16(1): 57-65.
3	Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(2): 167-92.
4	Zeng YJ, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer[J]. Semin Cancer Biol, 2022, 86(Pt 3): 566-82.
5	Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies[J]. Cancer Metastasis Rev, 2020, 39(4): 1179-203.
6	Hu X, Pan GZ, Luo JL, et al. Kuwanon H inhibits melanoma growth through cytotoxic endoplasmic reticulum stress and impaired autophagy flux[J]. J Agric Food Chem, 2023, 71(37): 13768-82.
7	Ma MJ, Luan XY, Zheng H, et al. A mulberry diels-alder-type adduct, kuwanon M, triggers apoptosis and paraptosis of lung cancer cells through inducing endoplasmic reticulum stress[J]. Int J Mol Sci, 2023, 24(2): 1015.
8	Koirala P, Seong SH, Zhou YJ, et al. Structure⁻Activity relationship of the tyrosinase inhibitors kuwanon G, mulberrofuran G, and albanol B from Morus species: a kinetics and molecular docking study[J]. Molecules, 2018, 23(6): 1413-26.
9	Motallebi M, Bhia M, Rajani HF, et al. Naringenin: a potential flavonoid phytochemical for cancer therapy[J]. Life Sci, 2022, 305: 120752-63.
10	Guo C, Huang QX, Wang YS, et al. Therapeutic application of natural products: NAD⁺ metabolism as potential target[J]. Phytomedicine, 2023, 114: 154768.
11	Rong L, Li ZD, Leng X, et al. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway[J]. Biomedecine Pharmacother, 2020, 122: 109726-40.
12	Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer[J]. Int J Mol Sci, 2022, 23(3): 1328-39.
13	Bradley RK, Anczuków O. RNA splicing dysregulation and the hallmarks of cancer[J]. Nat Rev Cancer, 2023, 23(3): 135-55.
14	Pu HC, Qian Q, Wang FL, et al. SchizandrinA induces the apoptosis and suppresses the proliferation, invasion and migration of gastric cancer cells by activating endoplasmic reticulum stress[J]. Mol Med Rep, 2021, 24(5): 787-92.
15	Song CR, Shen T, Kim HG, et al. 20(S)-protopanaxadiol from Panax ginseng induces apoptosis and autophagy in gastric cancer cells by inhibiting src[J]. Am J Chin Med, 2023, 51(1): 205-21.
16	Li X, Ma XL, Nan Y, et al. 18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway[J]. World J Gastroenterol, 2023, 29(23): 3622-44.
17	Guo QR, Zhou WM, Zhang GB, et al. Jaceosidin inhibits the progression and metastasis of NSCLC by regulating miR-34c-3p/Integrin α2β1 axis[J]. Heliyon, 2023, 9(5): e16158.
18	Park KR, Jeong Y, Lee J, et al. Anti-tumor effects of jaceosidin on apoptosis, autophagy, and necroptosis in human glioblastoma multiforme[J]. Am J Cancer Res, 2021, 11(10): 4919-30.
19	Liu J, Li SM, Tang YJ, et al. Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways[J]. Redox Rep, 2024, 29(1): 2313366-75.
20	Wei ZC, Chen J, Zuo F, et al. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: a review[J]. J Ethnopharmacol, 2023, 300: 115748.
21	Chimento A, de Luca A, D'Amico M, et al. The involvement of natural polyphenols in molecular mechanisms inducing apoptosis in tumor cells: a promising adjuvant in cancer therapy[J]. Int J Mol Sci, 2023, 24(2): 1680-9.
22	Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review[J]. Biomedecine Pharmacother, 2019, 112: 108612-23.
23	Li GZ, Doherty GM, Wang JP. Surgical management of gastric cancer: a review[J]. JAMA Surg, 2022, 157(5): 446-54.
24	Song SY, Su ZL, Xu H, et al. Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1[J]. Cell Death Dis, 2017, 8(2): e2612-25.
25	Sokolova O, Naumann M. Matrix metalloproteinases in Helicobacter pylori-associated gastritis and gastric cancer[J]. Int J Mol Sci, 2022, 23(3): 1883-95.
26	Wu LR, Qian CC, Zhang WQ, et al. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways[J]. Phytomedicine, 2023, 116: 154846-55.
27	Xia PF, Liang J, Jin D, et al. Reversine inhibits proliferation, invasion and migration and induces cell apoptosis in gastric cancer cells by downregulating TTK[J]. Exp Ther Med, 2021, 22(3): 929-43.
28	Wang C, Yang Z, Xu E, et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway[J]. Clin Transl Med, 2021, 11(8): e522-9.
29	Morgos DT, Stefani C, Miricescu D, et al. Targeting PI3K/AKT/mTOR and MAPK signaling pathways in gastric cancer[J]. Int J Mol Sci, 2024, 25(3): 1848-57.
30	Chen G, Zhang HH, Sun HX, et al. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway[J]. Apoptosis, 2023, 28(9/10): 1390-405.
31	Lee HJ, Venkatarame Gowda Saralamma V, Kim SM, et al. Pectolinarigenin induced cell cycle arrest, autophagy, and apoptosis in gastric cancer cell via PI3K/AKT/mTOR signaling pathway[J]. Nutrients, 2018, 10(8): 1043-52.
32	Zhang XR, Wang SY, Sun W, et al. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway[J]. Mol Med Rep, 2018, 18(3): 3429-36.

[1]	夏勇生, 王炼, 陈孝华, 张雨路, 孙奥飞, 陈德利. 过表达TSR2通过下调PI3K/AKT信号通路抑制胃癌细胞的增殖和侵袭[J]. 南方医科大学学报, 2024, 44(5): 913-919.
[2]	杨晶晶, 殷丽霞, 段婷, 牛民主, 何震东, 陈心蕊, 张小凤, 李静, 耿志军, 左芦根. 胃癌组织中高表达ATP5A1与患者术后的不良预后和肿瘤细胞的糖代谢有关[J]. 南方医科大学学报, 2024, 44(5): 974-980.
[3]	梁一豪, 赖颖君, 袁燕文, 袁炜, 张锡波, 张拔山, 卢志锋. 基于GEO数据库筛选胃癌差异表达基因及其功能和通路富集分析[J]. 南方医科大学学报, 2024, 44(3): 605-616.
[4]	沈梦迪, 赵娜, 邓晓晶, 邓敏. COX6B2在胃癌组织中高表达并影响患者的远期预后：基于抑制p53信号调控胃癌细胞的增殖及细胞周期[J]. 南方医科大学学报, 2024, 44(2): 289-297.
[5]	张诺, 张震, 张雨路, 宋雪, 张小凤, 李静, 左芦根, 胡建国. PCID2在胃癌组织中高表达并通过调控细胞周期进程和增殖影响患者预后[J]. 南方医科大学学报, 2024, 44(2): 324-332.
[6]	张文静, 张诺, 杨子, 张小凤, 孙奥飞, 王炼, 宋雪, 耿志军, 李静, 胡建国. BZW1 高表达促进胃癌细胞的侵袭和转移：基于调控Wnt//β-catenin通路和促进上皮间质转化[J]. 南方医科大学学报, 2024, 44(2): 354-362.
[7]	段婷, 张震, 施金冉, 肖林雨, 杨晶晶, 殷丽霞, 张小凤, 耿志军, 陆国玉. CPNE3在胃癌中高表达并与患者的预后不良相关[J]. 南方医科大学学报, 2024, 44(1): 129-137.
[8]	冯雯, 赖跃兴, 王静, 徐萍. 长链非编码RNA ABHD11-AS1促进胃癌细胞糖酵解并加速肿瘤恶性进展[J]. 南方医科大学学报, 2023, 43(9): 1485-1492.
[9]	王炼, 夏勇生, 张震, 刘馨悦, 施金冉, 王月月, 李静, 张小凤, 耿志军, 宋雪, 左芦根. 高表达MRPL13促进胃癌细胞增殖并影响患者预后：基于抑制p53信号[J]. 南方医科大学学报, 2023, 43(9): 1558-1566.
[10]	左芦根, 王炼, 杨子, 李骏杰, 王文锋, 李静, 王月月, 宋雪, 张小凤, 耿志军. 高表达CAMSAP2通过上调TGF-β信号促进胃癌细胞的侵袭和转移[J]. 南方医科大学学报, 2023, 43(9): 1460-1468.
[11]	王秋生, 张震, 王炼, 汪煜, 姚新宇, 王月月, 张小凤, 葛思堂, 左芦根. 高表达DAP5促进胃癌细胞的糖代谢并与不良预后相关[J]. 南方医科大学学报, 2023, 43(7): 1063-1070.
[12]	张浩, 张震, 王秋生, 王炼, 杨子, 耿志军, 王月月, 李静, 左芦根. FJX1在胃癌组织中高表达并与不良预后相关[J]. 南方医科大学学报, 2023, 43(6): 975-984.
[13]	葛菲, 万梦琪, 程振宇, 陈雪雷, 陈芊伊, 戚之琳. 芦荟苷可抑制胃癌细胞的增殖和迁移：基于下调STAT3/HMGB1信号通路[J]. 南方医科大学学报, 2023, 43(5): 702-709.
[14]	吴佳明, 邓忠权, 朱奕, 窦广健, 李进, 黄立勇. MicroRNA-431-5p在胃癌组织中低表达：基于线粒体和Bax/Bcl-2/caspase3信号通路[J]. 南方医科大学学报, 2023, 43(4): 537-543.
[15]	吕纯鑫, 吴秀奇, 夏青. 多原发恶性肿瘤合并SWI/SNF复合体缺陷型胃癌1例报告及文献复习[J]. 南方医科大学学报, 2023, 43(3): 495-498.

桑黄酮G通过调控PI3K/AKT/mTOR通路抑制胃癌细胞的生长、迁移和侵袭

Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 6

参考文献 32

相关文章 15

编辑推荐

Metrics

本文评价